---
figid: PMC9323376__ijms-23-07814-g004
pmcid: PMC9323376
image_filename: ijms-23-07814-g004.jpg
figure_link: /pmc/articles/PMC9323376/figure/ijms-23-07814-f004/
number: Figure 4
figure_title: ''
caption: 'Unkeito (UKT) reduces p65 expression in the NF-κB signaling pathway. Expression
  of (a) p65 and (b) p50 normalized to that of Gapdh; (c) p65 localization 72 h after
  RANKL stimulation in the presence or absence of UKT (n = 3; scale bar = 10 µm, 2
  µm); (d) p65 abundance in the nucleus. Error bars represent ± standard error of
  the mean. * p < 0.05; ** p < 0.01, versus control groups on the same day. Black
  box: control; gray box: UKT; NC: negative control; ND: not detected.'
article_title: Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1–Bcl6
  and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis.
citation: Ke Fang, et al. Int J Mol Sci. 2022 Jul;23(14):7814.
year: '2022'

doi: 10.3390/ijms23147814
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- osteoporosis
- postmenopause
- NFATc1
- p65
- caspase-3
- Unkeito

---
